Delivery Order SPE2DB22D1002-SPE2DB24FLAE6
- Not listed
- The U.S. Defense Logistics Agency (DLA) awarded a firm fixed price delivery order contract to AmerisourceBergen Drug Corp, a subsidiary of AmerisourceBergen Corporation, for the supply of ENGERIX-B 20 MCG/ML SYRNML pharmaceuticals. The contract has a ceiling value of $18,002.34 and a period of performance through March 18, 2024. This delivery order is part of a larger indefinite delivery contract (IDC) with a potential value of $999,999,999.00 awarded to AmerisourceBergen Drug Corp, which serves...
- The U.S. Defense Logistics Agency awarded a firm fixed price delivery order contract to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, to provide ENGERIX-B 20 MCG/ML SYRNML pharmaceutical products. The $1,627.60 contract has a completion date of February 12, 2024. Amerisourcebergen Drug Corp serves as the prime contractor and is responsible for delivering the requested pharmaceuticals to the DLA Troop Support Medical facilities in support of military treatment...
- The U.S. government's Defense Logistics Agency (DLA) Troop Support Medical awarded a firm fixed price delivery order contract to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, to provide ENGERIX-B 20 MCG/ML SYRNML, a pharmaceutical product, with a ceiling value of $76,007.40. This delivery order contract has an ultimate completion date of March 20, 2024. Amerisourcebergen Drug Corp is the prime contractor and the award does not have a set-aside designation. The...
- The U.S. Defense Logistics Agency (DLA) awarded a firm fixed price delivery order contract to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, to provide ENGERIX-B 20 MCG/ML SYRNML, a pharmaceutical product, with a potential value of $2,685.51 and a completion date of February 12, 2024. This award is not associated with any set-aside designations. Amerisourcebergen Drug Corp is the prime contractor and holds an indefinite delivery contract (IDC) with DLA, valued up...
- The Defense Logistics Agency (DLA) awarded a $3,195.31 firm fixed price delivery order contract to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, for the supply of ENGERIX-B 20 MCG/ML SYRNML pharmaceutical products. This delivery order is part of a larger indefinite delivery contract (IDC) awarded solely to Amerisourcebergen Drug Corp, with a potential value of $999,999,999.00 and a performance period through December 31, 2025. The IDC serves as the primary...
- The U.S. Defense Logistics Agency (DLA) Troop Support Medical awarded a firm fixed price delivery order contract worth $1,052.41 to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation. This order is for the supply of ENGERIX-B 20 MCG/ML SYRNML, a pharmaceutical product. The contract has a completion date of February 9, 2024 and was awarded on February 8, 2024. Amerisourcebergen Drug Corp is the prime contractor for this delivery order, which is not associated with any...
- The U.S. Defense Logistics Agency (DLA) awarded a firm-fixed-price delivery order contract worth $8,184.67 to Amerisourcebergen Drug Corp's Corporate Office Division. The contract is for the supply of 4,565,021,525 units of the ENGERIX-B 20 MCG/ML SYRNML pharmaceutical product. The contract has a period of performance through June 28, 2024 and does not have a set-aside designation. Amerisourcebergen Drug Corp is a major supplier of pharmaceutical products and medical supplies to various...
- The Defense Logistics Agency awarded a firm fixed price delivery order contract valued at $5,850.10 to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, for the supply of ENGERIX-B 20 MCG/ML SYRNML pharmaceutical product. This delivery order is part of an indefinite delivery contract (IDC) with a potential value of $999,999,999.00 that was awarded solely to Amerisourcebergen Drug Corp. The IDC serves as the primary contract vehicle for Amerisourcebergen to deliver...
- The Defense Logistics Agency (DLA) has awarded a firm fixed price delivery order contract to Amerisourcebergen Drug Corp, a for-profit pharmaceutical distribution company, for the supply of ENGERIX-B 20 MCG/ML SYRNML vaccines. The contract has a completion date of March 4, 2024 and a potential value of $1,992.72. This delivery order is part of a larger indefinite delivery contract (IDC) between DLA and Amerisourcebergen Drug Corp, valued at up to $999,999,999.00, to provide a comprehensive range...
- The Defense Logistics Agency (DLA) awarded a firm fixed price delivery order worth $39,528.02 to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation. The delivery order is for the provision of ENGERIX-B 20 MCG/ML SYRNML, a pharmaceutical product. This award is part of a larger indefinite delivery contract (IDC) held by Amerisourcebergen Drug Corp, valued at up to $999,999,999.00 and running through December 31, 2025. The IDC serves as the primary contract vehicle for...
- SPE2DB22D1002Indefinite Delivery Contract
- SPE2DB22D1002-SPE2DB24FLAE6Delivery Order
The U.S. Defense Logistics Agency (DLA) awarded a firm fixed price delivery order contract, SPE2DB22D1002|SPE2DB24FLAE6, to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, to provide 4,564,158,341 units of the pharmaceutical product ENGERIX-B 20 MCG/ML SYRNML. The contract has a ceiling value of $1,677.10 and a period of performance through April 4, 2024. Amerisourcebergen Drug Corp is the prime contractor, and there is no set-aside designation for this award. This delivery order is part of a larger indefinite delivery contract (IDC) awarded solely to Amerisourcebergen Drug Corp by DLA, with a potential value of up to $999,999,999.00 and a performance period through December 31, 2025. The IDC serves as Amerisourcebergen Drug Corp's primary contract vehicle for delivering pharmaceutical products and medical supplies to DLA Troop Support Medical facilities supporting the Department of Defense.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $1.7k | 4/3/24 |